Skip to content
  • HOME
  • ABOUT

    CPA is the leading national, bipartisan organization exclusively representing domestic producers and workers across many industries and sectors of the U.S. economy.

    • ABOUT CPA
    • STAFF
    • BOARD
    • CONTACT CPA
    • ABOUT CPA
    • STAFF
    • BOARD
    • CONTACT CPA
    LEARN MORE ➔
  • ISSUES

    CPA ADVOCACY ISSUES

    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
  • NEWSROOM
    Adam Smith's Enemy Was the East India Company, Not the Tariff of 1789

    Adam Smith’s Enemy Was the East India Company, Not the Tariff of 1789

    June 12, 2026

    THE LATEST

    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY
    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY

    Adam Smith’s Enemy Was the East India Company, Not the Tariff of 1789

    CPA Applauds Expanded Pentagon List of Chinese Military Companies

    Trade Deficit Falls in April, Driven Largely by Persian Gulf Disruptions

    Government Seeks To Enlist Small Business Involved In Critical Supply Chains

    MORE FROM THE NEWSROOM ➔
  • RESEARCH
  • CONTRIBUTE

    Help us take the next steps to strengthen America's domestic producers.

    Your generous contribution will enable us to keep fighting for the prosperous growth of an industrial strategy in many sectors such as Healthcare, Agriculture, Manufacturing, Trade, Technology & Tax.

    CONTRIBUTE TODAY ➔

Senate Takes Turn to End China Profiting Off of U.S. Federal Pensions

Archive, Capital Markets, China, commentary, Commentary Featured, Featured Home Page, Issues, NewsroomBy Kenneth RapozaJuly 24, 2023Leave a comment

Should federal government employees, including military commanders, be investing their retirement money in China? Some say no, and will try to stop it this week.

Government Pension Fund Managers Invested In China Fail To Preserve Retirement Savings

Archive, Capital Markets, commentary, Commentary Featured, Featured Home Page, Issues, NewsroomBy Kenneth RapozaJuly 17, 2023Leave a comment

Some in the Senate want to ban China from government retirement funds. Wall Street thinks it’s their fiduciary duty to be in China, despite losing money.

Government Incentives for Niche Sectors of Economy Leads to “Manufacturing Boom”

Archive, Commentary Featured, Featured Home Page, Issues, Newsroom, Trade and TariffsBy Kenneth RapozaJuly 10, 2023Leave a comment

The recent spending on manufacturing facilities is almost entirely due to two pieces of legislation. That won’t be enough for a real, manufacturing boom.

Are Americans Investing in Chinese Forced Labor Companies?

Archive, Capital Markets, China, commentary, Commentary Featured, Customs, Featured Home Page, Issues, NewsroomBy Kenneth RapozaJune 23, 2023Leave a comment

The House Select Committee on the CCP published a preliminary report on the use of forced labor in Shein and Temu supply chains. Many Americans are investors.

Taiwan Agreement Risks Treasury Rewriting Customs Law Globally

Featured Home Page, commentary, Commentary Featured, Newsroom, Trade and TariffsBy Charles BenoitJune 21, 2023Leave a comment

On June 1, 2023, the United States and Taiwan signed “the first agreement under the U.S.-Taiwan Initiative on 21st Century Trade.” “Initiative”? “21st Century Trade”?

FDA Allows Uninspected China Lab to Sell Cancer Drugs in the US

Archive, commentary, Commentary Featured, CPA News, Featured Home Page, Healthcare, Issues, Manufacturing, Newsroom, Supply ChainBy Kenneth RapozaJune 9, 2023Leave a comment

A Chinese cancer drug maker that has not been inspected by the FDA since 2018 is selling chemotherapy drugs to the U.S. due to shortages. When will the U.S. meet its critical medication needs?

To Fight Drug Shortages FDA Has an Idea: Import More Inspection-Free Drugs

Archive, Commentary Featured, Featured Home Page, Healthcare, Issues, NewsroomBy Kenneth RapozaJune 2, 2023Leave a comment

The balance between scarcity and supply favors supply, even if that means importing drugs from labs the FDA has not inspected.

Five China Companies Wall Street Still Funds Despite Being Blacklisted

Archive, Capital Markets, Commentary Featured, Featured Home Page, Issues, NewsroomBy Kenneth RapozaJune 2, 2023Leave a comment

Meet the Chinese companies banned by Commerce and the State Department, but still able to attract billions from Wall Street fund managers.

Is ‘Reshoring’ Happening? New Reports, CPA Index Tries to Measure the Evidence

Archive, Commentary Featured, Featured Home Page, Issues, Manufacturing, NewsroomBy Kenneth RapozaMay 11, 2023Leave a comment

A look at recent studies on whether companies are sourcing manufactured goods from outside of China (they are), and if any of it that manufacturing is coming home since tariffs were imposed in 2018.

Tariffs Good, ‘De Minimis’ Bad, in Latest House Ways & Means Hearing on Trade

Archive, China, commentary, Commentary Featured, Featured Home Page, Issues, Newsroom, Supply Chain, Trade and TariffsBy Kenneth RapozaMay 9, 2023Leave a comment

House Committee hears from witnesses who call for better trade enforcement, and keeping tariffs. Meanwhile, de minimis trade rule in the crosshairs again.

←1
23456789101112131415161718192021222324252627282930313233
…3435363738…
394041424344454647484950515253545556575859606162
63→
  • ABOUT
  • NEWSROOM
  • CONTACT
Facebook-f Youtube Linkedin

© 2026 COALITION FOR A PROSPEROUS AMERICA. ALL RIGHTS RESERVED.

Go to Top

⋆ ⋆ ⋆ MENU

  • HOME
  • ABOUT
    • ABOUT CPA
    • STAFF
    • BOARD
    • ADVOCACY
    • MEMBERSHIP
    • HISTORY
    • OUR MISSION
    • OUR VISION
    • CONTACT US
  • ISSUES
    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
  • RESEARCH
  • NEWSROOM
    • THE LATEST
    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY
  • CONTRIBUTE
Prosper Weekly

DON'T MISS IT!

Subscribe to CPA's exclusive weekly Newsletter ➔

 Share This
 Facebook
 LinkedIn
 Copy

Share on Mastodon